Opinion|Videos|October 24, 2024
Diagnosing IPF: Key Tests, Time to Diagnosis, and Importance of Early Detection
Author(s)Toby Maher, MD, PhD
Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) is diagnosed through specific imaging and tests, with an average diagnosis time that can delay effective treatment, emphasizing that early diagnosis is crucial for reducing disease severity and expanding available treatment options.
Advertisement
Video content above is prompted by the following:
- How is IPF diagnosed, including specific tests and/or imaging, and what is the average time to diagnosis?
- What role does early diagnosis play in the severity of disease and the treatment options offered to patients with IPF?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- AML Survival After 3 Years in Remission Comparable With General Population
September 20th 2025
- CSU More Burdensome in Female Patients, Especially in Midlife
September 20th 2025
- Rocatinlimab AD Combo Therapy Safe, Effective Over 24 Weeks
September 19th 2025
- Acute Exacerbations of IPF, PFF, Require Careful Clinical Decisions
September 19th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis
2
FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC
3
Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL
4
AHA Launches New Initiative to Help Patients With Heart Failure
5